A major portion of Wood Phillips' practice involves US and foreign patent procurement, patent validity/invalidity, infringement and freedom to operate opinions, licensing, protecting trade secrets, representing parties in reexamination and interference proceedings, and defending or enforcing patents in litigation in the biotechnology, pharmaceutical, agricultural and chemical fields.
Our extensive experience and grasp of IP issues and their effect on the client’s strategic goals allow us to effectively represent our clients and ensure that they maximize return on their IP portfolio. For example, we perform due diligence work and negotiations for mergers and acquisitions to assure the best possible price for your IP assets.
We have the industry expertise to effectively represent our clients in such areas as biochemistry, molecular biology, pharmaceuticals, biotechnology, medical devices, genetic modification, microbiology, regenerative medicine, stem cell biology, immunogenetics, organic chemistry, chemical engineering, and plant sciences. Wood Phillips attorneys include two former Chief Patent and Trademark Counsels for Fortune 100 healthcare companies who are particularly adept at providing bottom-line oriented solutions.
We have worked with all kinds of pharmaceutical, biochemical and diagnostic companies, from start-ups to Fortune 500 companies. Whether your company is large or small, we can help you achieve your goals in a cost-efficient manner.
These practice group designations indicate fields of interest and general experience. They do not indicate certified specialties and are not endorsed by any State Bar.